Workflow
Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Core Insights - The company believes that cell and gene therapy will be a significant transformation in medicine over the coming decades [1] - The industry has faced challenges, but the company remains optimistic about its progress and future developments [1] Company Perspective - The CEO emphasizes the importance of understanding stock catalysts while focusing on building the business [1] - The company is committed to navigating the complexities of the cell and gene therapy field [1]